GSK buys out Novartis in $13bln shake-up

ReutersNewsPublished: March 27, 2018
Published: March 27, 2018

GlaxoSmithKline said on Tuesday it will buy Novartis's 36.5 percent stake in their consumer healthcare joint venture for $13 billion in cash, and will also begin a strategic review of some other businesses. Kate King reports.

Be the first to suggest a tag

    Comments

    0 comments